Acropolis Investment Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,342
Closed -$102K 389
2026
Q1
$102K Buy
+1,342
New +$96.7K ﹤0.01% 378
2025
Q2
Sell
-1,348
Closed -$119K 264
2025
Q1
$119K Hold
1,348
0.01% 284
2024
Q4
$123K Hold
1,348
0.01% 290
2024
Q3
$151K Hold
1,348
0.01% 256
2024
Q2
$132K Hold
1,348
0.01% 259
2024
Q1
$135K Hold
1,348
0.01% 253
2023
Q4
$121K Sell
1,348
-535
-28% -$42.6K 0.01% 264
2023
Q3
$144K Hold
1,883
0.01% 242
2023
Q2
$158K Hold
1,883
0.01% 219
2023
Q1
$159K Sell
1,883
-1
-0.1% -$86 0.01% 217
2022
Q4
$153K Buy
1,884
+7
+0.4% +$564 0.01% 213
2022
Q3
$133K Hold
1,877
0.01% 210
2022
Q2
$168K Hold
1,877
0.02% 190
2022
Q1
$210K Hold
1,877
0.02% 181
2021
Q4
$227K Sell
1,877
-453
-19% -$50.4K 0.02% 176
2021
Q3
$232K Hold
2,330
0.03% 166
2021
Q2
$272K Buy
+2,330
New +$280K 0.03% 156

Other funds holding EMN

Acropolis Investment Management's EMN Position: Q2 2026 in Review

Acropolis Investment Management sold out of Eastman Chemical (EMN) in Q2 2026, closing a stake of 1,342 shares — an estimated $102K sold.

Acropolis Investment Management first reported a position in EMN in Q2 2021 and held it in 17 quarters. The position peaked at $272K in Q2 2021. 75 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Acropolis Investment Management reported no remaining Eastman Chemical position as of Q2 2026 after selling out during the quarter.
  • Acropolis Investment Management sold 1,342 Eastman Chemical shares in Q2 2026, an estimated $102K.
  • Acropolis Investment Management first reported a position in Eastman Chemical in Q2 2021 and held it in 17 quarters.
  • Acropolis Investment Management's Eastman Chemical position peaked at $272K in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Acropolis Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.